Funding Archives – Treatment Action Group

Treatment Action Group Calls on NY City Council to Override and Mayor Adams to Reverse Egregious Cuts to New York City HIV Funding

May 22, 2024
Dorrit Walsh

In response to disheartening news of the proposed $5.3 million cut in HIV/AIDS funding by the Adams administration, we at Treatment Action Group (TAG) express our resolute opposition, in solidarity with our partner organizations that would be harmed by the egregious, unconscionable cuts to HIV services and programs in New York City.

Report: TB R&D Funding Perilously Off Track of UN Commitments to End Disease by 2030

December 5, 2023
Dorrit Walsh

A new report released today by Treatment Action Group (TAG) and the Stop TB Partnership has found that cumulative funding for tuberculosis (TB) research and development (R&D) over the past five years is falling shockingly short of commitments.

Report cover - graphic representation of a target and the text reads: Tuberculosis Research Funding Trends, 2005-2022

2023 Report on TB Research Funding Trends

December 5, 2023
Dorrit Walsh

Tuberculosis Research Funding Trends 2005 – 2022, the 18th annual installment of our series assessing the state of TB R&D, is based on surveys of biomedical research funders conducted by TAG with support from Stop TB Partnership.

New TAG Analysis: Nearly All Countries “Far Off Track” of Meeting TB Research Targets Despite Publicly Reaffirming Commitments at UN

September 20, 2023
Dorrit Walsh

As international dignitaries and political leaders gather in New York City this week for the United Nations High-Level Meeting (HLM) on TB, a sobering new analysis from Treatment Action Group (TAG) shows that governments failed to meet previous commitments to fund TB research.

Information Note: New Fair Share Funding Targets for TB Research 0.1% -> 0.15%

August 16, 2023
Dorrit Walsh

In 2017 Treatment Action Group and partners introduced the “fair share” funding targets for TB research.

publication cover, which reads: tuberculosis research funding trends, 2005 - 2021. Cover is blue with "$1 BILLION" in text over various monetary signs from different countries. Logos at bottom are StopTBPartnership and TAG

2022 Report on TB Research Funding Trends

December 6, 2022
Dorrit Walsh

For the first time in history, funding for tuberculosis (TB) research and development (R&D) hit a billion dollars worldwide in 2021.

European Commitments to TB R&D Investments: Promises Made to Be Broken?

February 18, 2022
Dorrit Walsh

In this brief, TAG outlines the pathway the EU can take to scale up support for TB R&D, and advance the many European-sponsored TB vaccine candidates currently in the development pipeline.

TB Vaccine Advocacy Roadmap Calls for Increased EU Funding for TB Vaccine Development

February 16, 2022
Dorrit Walsh

TAG stands proudly alongside the TB community to issue this press statement calling for increasing European funding for TB vaccine development, just before the sixth Global Forum on TB Vaccines convenes in Toulouse, France.

Cover of Tuberculosis Research Funding Trends, 2005 - 2020. Cover illustration is a sheet of stamps. one says Institut pasteur, 1921-2021, le vaccin protege bcg vaccine protects. the second says 2021, invest in new end TB vaccines, 2030

2021 Report on TB Research Funding Trends

December 9, 2021
Dorrit Walsh

TAG’s latest report on global funding for TB research and development (R&D), published in collaboration with the Stop TB Partnership, presents new data on TB R&D funding in 2020 and analyzes trends in funding since 2005.

Cover of Tuberculosis Research Funding Trends 2005-2019

2020 Report on TB Research Funding Trends

December 7, 2020
Dorrit Walsh

TAG’s latest report on global funding for TB research and development (R&D), published in collaboration with the Stop TB Partnership, presents new data on TB R&D funding in 2019 and analyzes trends in funding since 2005.